GKOS vs. DXCM
GKOS (Glaukos Corporation) and DXCM (DexCom, Inc.) are both stocks. Both are in the Healthcare sector — GKOS in Medical Devices, DXCM in Diagnostics & Research. Over the past 10 years, GKOS returned 17.16%/yr vs 13.66%/yr for DXCM. Their 0.35 correlation means their historical movements had little consistent relationship.
Performance
GKOS vs. DXCM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GKOS achieves a 47.66% return, which is significantly higher than DXCM's 25.73% return. Over the past 10 years, GKOS has outperformed DXCM with an annualized return of 17.16%, while DXCM has yielded a comparatively lower 13.66% annualized return.
GKOS
- 1D
- -1.07%
- 1M
- 12.39%
- 6M
- 39.65%
- YTD
- 47.66%
- 1Y
- 93.50%
- 3Y*
- 29.54%
- 5Y*
- 26.73%
- 10Y*
- 17.16%
- ALL TIME*
- 17.03%
DXCM
- 1D
- 11.95%
- 1M
- 17.12%
- 6M
- 14.25%
- YTD
- 25.73%
- 1Y
- 5.26%
- 3Y*
- -11.89%
- 5Y*
- -8.33%
- 10Y*
- 13.66%
- ALL TIME*
- 16.87%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
DXCM DexCom, Inc. | $381.17M | $359.84M | $403.63M |
| $174.06M | $139.88M | $138.83M |
GKOS vs. DXCM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GKOS Glaukos Corporation | 47.66% | -24.70% | 88.63% | 81.98% | -1.71% | -40.95% | 38.17% | -3.03% | 118.99% | -25.22% |
DXCM DexCom, Inc. | 25.73% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
Correlation
The correlation between GKOS and DXCM is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.29 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.37 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.35 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2015 | 0.35 |
The correlation between GKOS and DXCM shifts across timeframes, from 0.22 (1 year) to 0.37 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
GKOS:
$9.83B
DXCM:
$32.20B
GKOS:
-$3.25
DXCM:
$2.51
GKOS:
15.73
DXCM:
6.68
GKOS:
14.27
DXCM:
12.47
GKOS:
$612.84M
DXCM:
$4.97B
GKOS:
$484.88M
DXCM:
$3.12B
GKOS:
-$152.64M
DXCM:
$1.41B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GKOS vs. DXCM — Risk / Return Rank
GKOS
DXCM
GKOS vs. DXCM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Glaukos Corporation (GKOS) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GKOS | DXCM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.71 | ||
| Sortino ratioReturn per unit of downside risk | +2.29 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.05 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 3.32 | 0.10 | +3.22 |
| Martin ratioReturn relative to average drawdown | 9.43 | 0.19 | +9.24 |
Loading charts...
Drawdowns
GKOS vs. DXCM - Drawdown Comparison
The maximum GKOS drawdown since its inception was -69.57%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for GKOS and DXCM.
Loading charts...
Drawdown Indicators
| GKOS | DXCM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.57% | -94.61% | +25.04% |
Max Drawdown (1Y)Largest decline over 1 year | -28.39% | -33.33% | +4.94% |
Max Drawdown (3Y)Largest decline over 3 years | -53.68% | -60.95% | +7.27% |
Max Drawdown (5Y)Largest decline over 5 years | -53.68% | -66.32% | +12.64% |
Max Drawdown (10Y)Largest decline over 10 years | -69.57% | -66.32% | -3.25% |
Current DrawdownCurrent decline from peak | -1.07% | -48.75% | +47.68% |
Average DrawdownAverage peak-to-trough decline | -27.54% | -36.14% | +8.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.97% | 17.53% | -7.56% |
Volatility
GKOS vs. DXCM - Volatility Comparison
The current volatility for Glaukos Corporation (GKOS) is 11.45%, while DexCom, Inc. (DXCM) has a volatility of 15.95%. This indicates that GKOS experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GKOS | DXCM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.45% | 15.95% | -4.50% |
Volatility (6M)Calculated over the trailing 6-month period | 39.75% | 29.74% | +10.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.35% | 42.91% | +10.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.14% | 47.22% | +1.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.42% | 48.66% | +3.76% |
Dividends
GKOS vs. DXCM - Dividend Comparison
Neither GKOS nor DXCM has paid dividends to shareholders.
Financials
GKOS vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between Glaukos Corporation and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GKOS vs. DXCM - Profitability Comparison
GKOS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Glaukos Corporation reported a gross profit of 151.59M and revenue of 185.61M. Therefore, the gross margin over that period was 81.7%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported a gross profit of 830.00M and revenue of 1.31B. Therefore, the gross margin over that period was 63.4%.
GKOS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Glaukos Corporation reported an operating income of -17.27M and revenue of 185.61M, resulting in an operating margin of -9.3%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported an operating income of 318.30M and revenue of 1.31B, resulting in an operating margin of 24.3%.
GKOS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Glaukos Corporation reported a net income of -18.38M and revenue of 185.61M, resulting in a net margin of -9.9%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported a net income of 249.10M and revenue of 1.31B, resulting in a net margin of 19.0%.
Frequently Asked Questions
GKOS and DXCM have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DXCM has higher volatility (15.95%) compared to GKOS (11.45%). In terms of maximum drawdown, GKOS dropped -69.57% vs DXCM's -94.61%.
GKOS currently has the higher Sharpe Ratio (1.79 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GKOS and DXCM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer